Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer.
about
Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patternsIsolation and characterization of a novel zinc-finger protein with transcription repressor activityIdentification of rapid turnover transcripts overexpressed in thyroid tumors and thyroid cancer cell lines: use of a targeted differential RNA display method to select for mRNA subsetsA gene in the chromosomal region 3p21 with greatly reduced expression in lung cancer is similar to the gene for ubiquitin-activating enzymeStructure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor geneLack of expression of aminoacylase-1 in small cell lung cancer. Evidence for inactivation of genes encoded by chromosome 3pEvidence for increased in vivo mutation and somatic recombination in Bloom's syndromeRegional localization of chromosome 3-specific DNA fragments by using a hybrid cell deletion mapping panelScotin, a novel p53-inducible proapoptotic protein located in the ER and the nuclear membraneA model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting.The ninth Gordon Hamilton-Fairley memorial lecture. Hereditary cancers: clues to mechanisms of carcinogenesis.Molecular mechanisms of cancer.Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell linesSkin fibroblasts from individuals hemizygous for the familial adenopolyposis susceptibility gene show delayed crisis in vitro.High-resolution whole-genome analysis of skull base chordomas implicates FHIT loss in chordoma pathogenesisMolecular evidence that homologous recombination occurs in proliferating human somatic cells.Localization of human ERBA2 to the 3p22----3p24.1 region of chromosome 3 and variable deletion in small cell lung cancer.Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma.Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified.Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification.Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cellsTumor suppressors on 3p: a neoclassic quartetOrphan receptor COUP-TF is required for induction of retinoic acid receptor beta, growth inhibition, and apoptosis by retinoic acid in cancer cellsOverexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells.Construction of a human chromosome 3 specific NotI linking library using a novel cloning procedure.Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lungLoss of heterozygosity on chromosome 1q in human breast cancer.Cooperation of c-raf-1 and c-myc protooncogenes in the neoplastic transformation of simian virus 40 large tumor antigen-immortalized human bronchial epithelial cells.Restriction fragment length polymorphism studies show consistent loss of chromosome 3p alleles in small cell lung cancer patients' tumorsChromosomal imbalances in human lung cancer.Multistage models for carcinogenesisOncogenes and tumor-suppressor genes.Functional in vitro assays for the isolation of cell transformation effector and suppressor genes.Loss of heterozygosity for alleles on chromosome II in cervical carcinoma.Identification of two cosmids derived from within chromosomal band 3p21.1 that contain clusters of rare restriction sites and evolutionarily conserved sequences.Chromosome breakage and recombination at fragile sitesLoss of heterozygosity in a gene coding for a thyroid hormone receptor in lung cancers.Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancerPharmacogenomics: a reality or still a promise?
P2860
Q24311901-759DE657-B7D1-4C33-B81B-154A457ADB8AQ24337444-016D76C1-1C5B-4528-A4F1-49565C8455BBQ24545293-93B2C088-A450-48C0-B6AA-9211607CBCD9Q24562326-5573D4D5-CF3A-4A73-902D-07299D5DFAFDQ24564119-0DC19E50-BD8F-48AA-BBC8-A36769BEBEC1Q24622434-BFA84795-EB55-4BF4-961B-8D0BC71BB3A7Q24627875-F81E3A6E-1665-4981-93AD-0D32B002BC72Q24679206-D1B53DE7-2940-4B3D-83CA-4862EF3C23EFQ28507684-7A534F11-3EB2-4C54-B856-3CD3F6191B81Q30450833-0818AE2E-54E4-4C3D-BE47-8ED010A5A87BQ30486894-6DF0649B-E90E-4570-BB0F-462107EBD887Q30498610-3FC8DA95-D2E7-4CDB-B512-9994F40B4430Q30502375-97566FDD-0277-4F7F-B224-1C4A1D7B3200Q30532766-4D0BF77F-4B0A-4E10-9BE9-4EAAA180C293Q33274578-B8F33A7E-0C8B-41C1-94F7-4EFEBDEC9891Q33617612-ED73F4E7-423B-45EB-97CA-19CD0C8518AEQ33682080-87CCB436-DBC1-4477-8F59-83F38F5B97F0Q33772796-2E0CCF5A-35C8-467C-A2B0-3467DE0889E4Q33825340-3B583AD3-2F42-4D86-9CB4-8FA43B0DB65DQ33828498-752F3467-A98F-4790-9EC1-AB366F795E89Q33858202-BE471935-3C21-4C03-A846-596384746AC9Q33937895-74AF81A8-0C1B-4884-97C2-0039F5C53690Q33952593-7044973B-03AD-426C-A163-F52412EA6F30Q33961750-7420A341-3D4E-464F-B3C3-FE4FB5A2CD76Q34094407-B43DF9C1-8023-4E3A-A240-B7813FF2E180Q34205635-B8F02F08-B2BD-4784-9B11-B7C70D0F7321Q34287423-D36BD44C-C262-4215-81F0-856FB1689573Q34304686-142FB623-8EA1-4EA2-B692-C8895062A602Q34326650-5779317F-6EE3-4737-BCA6-2026E08D5356Q34559345-29DBEA18-1714-45FE-AA21-F657A8CC880EQ34935902-4CFDE42E-D1BE-4444-935A-134E90C56C69Q35032734-936CBEB5-49BF-4691-BEEB-09978645411CQ35034093-ABC9BB32-919B-4454-89EE-BEF281AE9AD5Q35034193-F62E7B8E-CA4C-4AE0-8516-8AC0C5A904F3Q35196851-60DEB8AC-333D-424D-AB11-096C5AB0C9FAQ35197355-577184AF-EEE1-4ED3-9F85-AC8DC9A5BCBEQ35246834-953412A8-E432-402E-AD7E-D5270E9AD216Q35246960-D18C22CE-5FD3-4197-A324-DAE2FC5D4ACEQ35477427-AF2F292A-7153-479C-85A5-748BCB0AFEF7Q35565186-12658AF3-5CA8-4A81-AADC-1369CC36616C
P2860
Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer.
@en
type
label
Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer.
@en
prefLabel
Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer.
@en
P2093
P356
P1433
P1476
Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer.
@en
P2093
Johnson BE
Sakaguchi AY
P2888
P304
P356
10.1038/329451A0
P407
P577
1987-10-01T00:00:00Z
P6179
1038445783